Most Recent Articles
Case Study: The Benefits of Vascularized Fibular Graft After Bone Tumor Resection
Published on
This case study highlights a multimodal approach to surgical management of osteosarcomas in young children, maximizing control while providing a functional limb that will grow with the child.
CHOP Welcomes World-Renowned Sarcoma Expert
Published on
Patrick J. Grohar, MD, PhD, focuses on developing therapies for a cancer that’s rare in adults but relatively common in the pediatric population.
Cancer Predisposition in Children: Increasing Awareness
Published on
A CHOP program is focused on identifying children who are predisposed to develop cancer and using surveillance testing to detect cancers early.
AML Immunotherapy Trial Opens
Published on
CHOP has opened a phase 1 trial using CAR T for tough acute myeloid leukemia, hoping to replicate the therapy’s success for acute lymphoblastic leukemia.
Immunotherapy: What’s Next for CAR-T Therapy
Published on
Trials of more game-changing cell therapies for pediatric cancer and other diseases are underway or on the horizon at Children's Hospital of Philadelphia.
New Program Focuses on Bone and Soft Tissue Tumors
Published on
CHOP recently launched a Bone and Soft Tissue Tumor Program, a collaboration between teams from Orthopedics and Oncology.
Child Life Services Are One Way CHOP Offers Psychosocial Support to Inpatients
Published on
The Psychosocial Services Program in the Division of Oncology at Children’s Hospital of Philadelphia provides comprehensive psychosocial services for children with cancer and members of their families.
Creating a Positive Outpatient Experience
Published on
Members of the CHOP Cancer Center team work to ensure that our patients’ and families’ transition to outpatient care is smooth and successful.
Caring for Maya: PCP and Oncologist Coordination
Published on
CHOP oncologists and primary care providers work closely with each other and with families to meet the needs of children with cancer.
Cancer Immunotherapy Stories Shared at the Vatican
Published on
CHOP's revolutionary T-cell immunotherapy was featured at “Cellular Horizons: The Third International Conference on the Progress of Regenerative Medicine and Its Cultural Impact,” an exclusive international event at the Vatican.